Evolent Health (EVH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Core Insights - Evolent Health reported revenue of $646.54 million for the quarter ended December 2024, reflecting a year-over-year increase of 16.3% but falling short of the Zacks Consensus Estimate by 1.48% [1] - The company's EPS was -$0.02, a decline from $0.23 in the same quarter last year, with no surprise against the consensus EPS estimate of -$0.02 [1] Financial Performance Metrics - Evolent Health's shares have returned +5.2% over the past month, outperforming the Zacks S&P 500 composite's +2.6% change, and currently holds a Zacks Rank 3 (Hold) [3] - Average PMPM Fees / Revenue per Case for the Performance Suite was $21.32, slightly below the estimated $21.81 [4] - Average PMPM Fees / Revenue per Case for the Specialty Technology and Services Suite matched the estimate at $0.37 [4] - Average PMPM Fees / Revenue per Case for Administrative Services was $16.43, exceeding the estimate of $15.44 [4] - Average Lives on Platform for Cases was 16 thousand, surpassing the estimate of 14.27 thousand [4] - Average Lives on Platform for the Performance Suite was 7.15 million, slightly below the estimate of 7.19 million [4] - Average Lives on Platform for the Specialty Technology and Services Suite was 75.16 million, compared to the estimate of 75.59 million [4] - Average Lives on Platform for Administrative Services was 1.2 million, below the estimate of 1.27 million [4] - Average PMPM Fees / Revenue per Case for Cases was $3,073, exceeding the average estimate of $2,976.69 [4]